No­vo Nordisk to cut in­sulin prices by up to 75% in 2024

No­vo Nordisk is cut­ting the price of its in­sulin prod­ucts by up to 75%, the com­pa­ny an­nounced on Tues­day.

Be­gin­ning in Jan­u­ary 2024, No­vo Nordisk will slash the price of brand name No­voLog and No­voLog Mix 70/30 in­sulin prod­ucts by 75%, and No­volin and Lev­emir prod­ucts by 65%.

A No­vo Nordisk spokesper­son said the changes have “been in de­vel­op­ment for many months, but due to in­creased stake­hold­er in­ter­est, we ac­cel­er­at­ed to an­nounce now.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER